Amgen is introducing Amjevita (adalimumab-atto), a biosimilar to AbbVie’s Humira. Amjevita was the first biosimilar to Humira approved by the Food and Drug Administration in 2016. "With today's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results